Author Summary
COPD and Immunotherapy in NSCLC
Background and rationale Lung cancer remains the leading cause of cancer-related mortality worldwide; non-small cell lung cancer (NSCLC) accounts for about 85% of cases. Despite advances, prognosis is poor, especially at advanced stages. Immune checkpoint […]